Picture of Isofol Medical AB (publ) logo

ISOFOL Isofol Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Isofol Says Has Received First Results From Laboratory Tests Of Arfolitixorin

Dec 7 (Reuters) - Isofol Medical AB (publ)  ISOFOL.ST :
    * ISOFOL HAS RECEIVED FIRST RESULTS FROM LABORATORY TESTS OF
ARFOLITIXORIN
    * FURTHER LABORATORY TESTS ARE ONGOING AND FULL RESULTS FROM
PRECLINICAL EVALUATION ARE EXPECTED TO BE DELIVERED IN EARLY
2024
    * ISOFOL MEDICAL-DATA GENERATED SO FAR FROM FIRST
EXPERIMENTS SHOW
NO DIFFERENCE IN ADDITIONAL EFFECT OF ARFOLITIXORIN COMPARED TO
LEUCOVORIN
    * HIGHER DOSES OF ARFOLITIXORIN THAN WAS USED IN AGENT STUDY
HAVE
BEEN TESTED, BUT WITH NO BETTER EFFECT

Source text for Eikon:  ID:nWkrb9r1FM 
Further company coverage:  ISOFOL.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Isofol Medical AB (publ)

See all news